Clinical trials
Phase 2 Recurrence trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
61 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 4 |
| 2010 | 1 |
| 2012 | 3 |
| 2013 | 6 |
| 2014 | 5 |
| 2015 | 4 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 8 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 39 |
| Terminated | 8 |
| Active, not recruiting | 7 |
| Unknown status | 4 |
| Recruiting | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 6 |
| Celgene | 5 |
| Novartis Pharmaceuticals | 5 |
| University College, London | 4 |
| Pfizer | 3 |
| University of Leeds | 3 |
| AbbVie | 2 |
| Daiichi Sankyo | 2 |
| University Hospital Southampton NHS Foundation Trust | 2 |
| University of Birmingham | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 61 |
| Multiple Myeloma | 9 |
| Neoplasms | 8 |
| Lymphoma | 7 |
| Lymphoma, Non-Hodgkin | 7 |
| Leukemia | 6 |
| Lymphoma, Large B-Cell, Diffuse | 6 |
| Neoplasm Metastasis | 5 |
| Head and Neck Neoplasms | 4 |
| Lymphoma, Follicular | 4 |
Trials
Showing 1 to 25 of 61. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.